Jan 2020

ANTG RECEIVES LICENCE TO EXPORT MEDICINAL CANNABIS FLOWER

We’re thrilled to announce we have received our export licence from the Drug Control Section of the ODC (Office of Drug Control). We’re firmly on course to continue to lead the way and be the first medicinal cannabis company in Australia to export cannabis flower to the EU since export was legalised in 2018.

The export of our first commercial crop into the EU provides a significant opportunity for us to scale up our operations and allows us to gather learnings that can support the Australian market. ANTG’s priority remains to provide superior quality medicinal cannabis for local patients in Australia. We continue to invest in research and development to find new applications for medicinal cannabis use and have submissions with regulators to cultivate and distribute medicinal cannabis for patients in Australia.

ANTG appoints new Business Operations Manager   Australian Natural Therapeutics […]

READ MORE >

ANTG’s Eve Cannabis product reveals its potential to kill or inhibit cancer cells without impacting normal cells…

READ MORE >

ANTG has listed two new THC-dominant medicinal cannabis strains on the Australian Register of Therapeutic Goods (ARTG).

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >